GLP-1s and Pregnancy/Family Planning

If you’re taking a GLP-1 medication and thinking about starting a family — or if you just found out you’re pregnant and you’re panicking — this is the page you need. Take a breath. The information here is clear, it’s based on the best evidence available, and it’s not going to sugarcoat anything or scare you unnecessarily.

Here’s the headline, up front: GLP-1 medications are not approved for use during pregnancy. Every FDA label for these medications says the same thing — discontinue if pregnancy occurs or is planned.[1] That’s not a gray area.

But there’s a lot more to this conversation than that one line. There’s the question of when to stop before trying to conceive, what happens if you find out you’re pregnant while still on the medication, how these drugs interact with birth control, and why fertility clinics are suddenly seeing a surge of patients who got pregnant unexpectedly on GLP-1s. All of that matters, and all of it deserves a clear explanation.

---

Why GLP-1s Are Contraindicated in Pregnancy

The word “contraindicated” means a medication shouldn’t be used in a specific situation — in this case, pregnancy. And with GLP-1 medications, the reason is straightforward: the safety data isn’t there.

Animal studies — which are how drug safety in pregnancy gets evaluated before human data exists — showed concerning results. In rats and rabbits given semaglutide and tirzepatide during pregnancy, researchers observed birth defects, pregnancy losses, and reduced fetal growth.[1] These studies used doses that were clinically relevant (adjusted for body surface area), not absurdly high test doses.

Now, animal studies don’t always predict what happens in humans. But when animal data raises red flags and there’s no large-scale human safety data to counter it, the FDA takes the cautious position. And rightfully so.

The bottom line: no one is saying these medications definitely cause harm in human pregnancies. What they’re saying is that we don’t have enough evidence to say they’re safe — and when you’re talking about fetal development, “we’re not sure” means “don’t use it.”

---

The “Ozempic Baby” Phenomenon

You’ve probably seen the headlines. Women who struggled with infertility for years suddenly getting pregnant after starting a GLP-1 medication. Fertility clinics reporting unexpected pregnancies. The phrase “Ozempic babies” trending on social media.

This is real. It’s not just media hype. But the biology behind it is more specific than the headlines suggest. Two mechanisms are driving this trend:

Semaglutide is different. A dedicated pharmacokinetic study showed that semaglutide does not significantly reduce oral contraceptive bioavailability — meaning the pill’s effectiveness isn’t meaningfully changed.[4] The UK’s Faculty of Sexual and Reproductive Healthcare (FSRH) has noted that GI side effects like vomiting and diarrhea from any GLP-1 could theoretically impair absorption on those specific days, but semaglutide itself doesn’t have the same pharmacokinetic interaction that tirzepatide does.

---

Washout Timelines: When to Stop Before Trying to Conceive

If you’re planning a pregnancy, you’ll need to stop your GLP-1 medication in advance. How far in advance depends on which medication you’re taking. The general principle is waiting at least five half-lives — the time it takes for the drug to clear your system almost completely.

The FDA label for semaglutide specifically states at least 2 months before planned pregnancy.[1] That’s the most conservative timeline of the group because semaglutide has the longest half-life among commonly used GLP-1 medications.

For tirzepatide, five half-lives works out to about 25 days. For liraglutide, the much shorter half-life means the drug clears within a couple of days.

From my experience, this is a conversation to have with your provider well before you start trying to conceive — not the month you want to start. Your provider can help you plan the transition, manage any weight changes during the washout period, and make sure you have a solid plan in place.

---

What If You Discover You’re Pregnant on a GLP-1?

This is the scenario that causes the most anxiety. You’re taking a GLP-1 medication and you find out you’re pregnant. Maybe you missed a period. Maybe a test came back positive unexpectedly. The first thing to know: stop the medication and contact your provider. That’s the immediate step.

The second thing to know — and this is important — is that the early human data is more reassuring than the animal data suggested it might be.

A 2024 study across six countries looked at 168 pregnancies where women were exposed to GLP-1 medications in the first trimester. The rate of major birth defects was 2.6% — compared to 2.3% in a matched control group of women with diabetes who weren’t exposed. That difference was not statistically significant.[2]

A separate 2024 study published in JAMA Internal Medicine analyzed 938 pregnancies with first-trimester GLP-1 exposure across Nordic countries, the US, and Israel. The relative risk for major malformations was 0.95 — meaning no increased risk was detected compared to women using insulin.[3]

These numbers matter. “No signal detected” is not the same as “proven safe” — the studies are still relatively small, and researchers are clear about that limitation. But for someone who just found out they were exposed in early pregnancy, the existing evidence does not show the pattern of harm that the animal studies predicted. That’s genuinely reassuring.

---

Contraception: What Works and What Needs Backup

This is practical information that doesn’t always make it into the prescription conversation.

These non-oral methods bypass the GI tract entirely, so delayed gastric emptying — the mechanism that creates the issue — doesn’t apply.

The takeaway: if you’re on a GLP-1 and want the most reliable contraception possible, non-oral methods eliminate the question entirely.

---

Breastfeeding and GLP-1 Medications

Every GLP-1 medication label says there’s insufficient data on use during breastfeeding. That’s been the standard answer — until recently.

A 2024 study published in Nutrients directly measured semaglutide levels in breast milk from 8 women who were taking the medication while breastfeeding. The result: semaglutide was not detected in any breast milk sample. The calculated relative infant dose (RID) — a standard measure of how much drug an infant would be exposed to through breast milk — was 1.26%, well below the 10% threshold that’s generally considered acceptable.[6]

That’s encouraging, but it’s also a study of 8 women. It’s not the kind of large-scale data that changes FDA labeling. It’s a first signal — and a positive one.

There are other considerations beyond whether the drug itself transfers into breast milk:

---

Male Fertility

This conversation usually centers on women, but it’s worth a brief note: emerging research suggests GLP-1 medications may actually have beneficial effects on male fertility.

Obesity is associated with lower testosterone, reduced sperm quality, and impaired reproductive function. Early studies suggest that GLP-1 treatment in men with obesity or Type 2 diabetes improves testosterone levels and sperm parameters — likely through the same weight loss and metabolic improvement that drives other benefits. The data is limited and early-stage, but the direction is positive rather than concerning.

---

The Pre-Pregnancy Window: GLP-1 Benefits Before Conception

Here’s something that doesn’t get enough attention: using GLP-1 medications before pregnancy — and stopping with an appropriate washout — may actually improve pregnancy outcomes.

A 2025 study in the American Journal of Obstetrics and Gynecology found that women who used GLP-1 medications in the two years before pregnancy had lower rates of gestational diabetes (15.2% vs. 18.2%), lower rates of hypertensive disorders, and lower rates of preterm delivery compared to matched controls.

The logic makes sense. Going into pregnancy at a healthier weight, with better metabolic markers, sets up better conditions for both the pregnancy and the baby. This is exactly why the Endocrine Society’s 2025 guidelines emphasize preconception counseling for women with diabetes who are considering GLP-1 treatment — the medications can be a useful tool in the preparation phase, even though they need to be stopped before conception.[8]

One counterpoint worth noting: a 2025 JAMA study found that women who discontinued GLP-1 medications before pregnancy had more gestational weight gain than expected (13.7 kg vs. 10.5 kg in controls).[7] That rebound effect — which we cover in the Long-Term Journey section of this guide — doesn’t disappear just because you stopped for pregnancy. Your provider can help you plan for that.

---

What the Professional Guidelines Say

The major medical organizations are aligned on this:

1. Endocrine Society (2025) — Discontinue GLP-1 medications before conception. Preconception counseling recommended for all women of reproductive age on these medications.[8]
2. American Diabetes Association (2025-2026) — GLP-1 receptor agonists are not recommended during pregnancy. Insulin remains the preferred medication for managing diabetes during pregnancy.
3. FDA — All GLP-1 medication labels carry pregnancy warnings advising discontinuation at least 2 months before planned conception (semaglutide) or upon discovering pregnancy.

None of these organizations are saying GLP-1 medications are dangerous in early pregnancy — the human data hasn’t shown that. What they’re saying is that until we have definitive safety data, the standard of care is to stop before conception and use medications with established pregnancy safety profiles (like insulin for blood sugar management).

---

The Bottom Line

GLP-1 medications and pregnancy don’t mix — that’s the clear consensus from every regulatory body and professional organization. But this isn’t a panic situation. It’s a planning situation.

If you’re thinking about pregnancy, talk to your provider about washout timelines well in advance. If you’re relying on oral birth control while taking tirzepatide, use a backup method. If you’re on any GLP-1 and not planning a pregnancy, make sure your contraception strategy is solid — because these medications can restore fertility in people who didn’t think they were fertile.

And if you’ve just discovered you’re pregnant while on a GLP-1, stop the medication and call your provider — but know that the early human data has not detected the risks that animal studies raised. That’s not a guarantee, but it is genuinely reassuring.

This is one of those conversations where the best thing you can do is plan ahead. You have the information now. Use it.

---